The FDA’s authorization of COVID-19 shots for children ages 6 months to 4 years will bring relief for millions of parents. Pending CDC endorsement, shots for this group will be available within days.
Academic rigor, journalistic flair
Articles on SARS-CoV-2 vaccine
Displaying 1 - 20 of 26 articles
Achieving herd immunity via vaccination was always going to be a hard ask. Now it’s mathematically impossible.
The COVID-19 vaccines continue to be effective against severe illness leading to hospitalization and death in all age groups, including children ages 5 to 11.
Moderna will ask the FDA to allow emergency use for its vaccine in children as young as 6 months, a step many parents have been anticipating.
A robust body of research finds that getting vaccinated against COVID-19 during pregnancy is safe and effective – and the best way to protect both mother and child from the risks of COVID-19.
The COVID-19 pandemic has brought immunology terms that are typically relegated to textbooks into our everyday vernacular. These stories helped us make sense of the ever-evolving science.
Some of the omicron variant’s unique properties – such as its ability to spread rapidly while causing milder COVID-19 infections – could usher in a new phase of the pandemic.
It’s too early to say whether the newly identified omicron variant is going to overtake delta. But particular mutations in the new strain have researchers deeply concerned.
Pediatric clinical trials for the COVID-19 Pfizer vaccine for children ages 5 to 11 have shown that the Pfizer shot is safe and effective.
As boosters are authorized for all three COVID-19 shots available in the US, the ability to swap out vaccine types looks to be a boon to the immune system.
An FDA panel has voted against recommending approval of a booster COVID-19 shot for the general population – disappointing some public health officials.
COVID can cause heart inflammation, abnormal heart rhythms, blood clots in the legs and lungs, stroke, and heart failure.
Recovering from COVID and then getting vaccinated, known as hybrid immunity, is more potent than being infected or vaccinated alone.
Vaccines can’t provide 100% protection, so it’s not a failure or surprise when some vaccinated people get sick with COVID-19. The good news is their cases are much less likely to be severe or fatal.
ATAGI is grappling with competing concerns, considerable uncertainty, and a constantly changing landscape.
Preliminary evidence suggests Lambda has an easier time infecting our cells and is a bit better at dodging our immune systems. But vaccines should still do a good job against it.
As many teens and adults in the US restart their social lives, parents of children under the age of 12 wonder when their kids will also be able to experience the freedom that comes with vaccination.
COVID vaccines don’t contain any live virus to shed. Here’s the science to put the myth of viral shedding after the COVID vaccine to bed.
Various companies use different ingredients and different delivery systems in their COVID-19 vaccines. Researchers are investigating whether it’s better for individuals to mix what’s available.
The COVID-19 vaccines are a smash success. But that doesn’t mean they keep every vaccinated person completely free of the coronavirus.
Top contributors
-
Associate Professor of Pediatrics, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Pediatric Infectious Diseases Fellow, University of Pittsburgh
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pediatrics, University of Pittsburgh
-
Professor and Department Chair of Infectious Diseases and Microbiology, University of Pittsburgh
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Associate Professor of Biology, Rochester Institute of Technology
-
Instructor of Human Immunology, Emory University
-
Dean Emeritus and Distinguished Service Professor Emeritus of Pharmacy, University of Pittsburgh
-
Doctorante en virologie moléculaire, Institut national de la recherche scientifique (INRS)
-
Professor (Microbiology & Molecular Virology) and Executive Dean: Faculty of Health Sciences, University of Johannesburg, University of Johannesburg
-
Assistant professor , Institut national de la recherche scientifique (INRS)
-
Professor of Molecular Immunology and Virology, Institute of Medical Sciences, Banaras Hindu University
